[Therapeutic and prophylactic effectiveness of carbochromen in experimental myocardial infarct].
D000284:Administration, Oral; D000818:Animals; D003374:Coumarins / Q000008:administration & dosage / Q000627:therapeutic use*; D004048:Diethylamines / Q000008:administration & dosage / Q000627:therapeutic use; D004195:Disease Models, Animal; D004285:Dogs; D004341:Drug Evaluation; D004562:Electrocardiography; D006016:Glycolates / Q000008:administration & dosage / Q000627:therapeutic use; D008026:Ligation; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology / Q000517:prevention & control; D013194:Staining and Labeling; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D003374:Coumarins; D004048:Diethylamines; D006016:Glycolates; D014665:Vasodilator Agents
L'efficacité thérapeutique et prophylactique du carbochromène dans l'infarctus myocardique expérimental